Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study.
Ioannis N PetropoulosFatima Al-ShibaniGulfidan BitirgenGeorgios PonirakisAdnan KhanHoda GadZiyad R MahfoudHeba AltarawnehMuhammad Hassan RehmanKaren JohnDhabia Al-MerekhiPooja GeorgeAli Ulvi UcaAhmet OzkagniciFaiza IbrahimReny FrancisBeatriz CanibanoDirk DeleuAhmed El-SotouhySurjith VattothAhmed OwnAshfaq ShuaibNaveed AkhtarSaddat KamranRayaz Ahmed MalikPublished in: Therapeutic advances in neurological disorders (2023)
Progressive corneal and retinal axonal loss was identified in patients with MS, especially those with more active disease. CCM may serve as an imaging biomarker of axonal loss in MS.